Search

Your search keyword '"Suppressa, Patrizia"' showing total 283 results

Search Constraints

Start Over You searched for: Author "Suppressa, Patrizia" Remove constraint Author: "Suppressa, Patrizia"
283 results on '"Suppressa, Patrizia"'

Search Results

3. Sex-related differences in response to lomitapide in HoFH: A subanalysis of the Pan-European Lomitapide retrospective observational study

4. Obstructive sleep apnea syndrome (OSAS) in women: A forgotten cardiovascular risk factor

5. Hyperhomocysteinemia is linked to MASLD

6. Association of BMI, lipid-lowering medication, and age with prevalence of type 2 diabetes in adults with heterozygous familial hypercholesterolaemia: a worldwide cross-sectional study

9. Impact of SARS-CoV-2 infection in patients with hereditary hemorrhagic telangiectasia: epidemiological and clinical data from the comprehensive Italian retrospective multicenter study

10. Familial hypercholesterolaemia in children and adolescents from 48 countries: a cross-sectional study

11. Refinement of the diagnostic approach for the identification of children and adolescents affected by familial hypercholesterolemia: Evidence from the LIPIGEN study

12. Evaluation of lipoprotein(a) in the prevention and management of atherosclerotic cardiovascular disease: A survey among the Lipid Clinics Network

13. The SIMI Gender ‘5 Ws’ Rule for the integration of sex and gender-related variables in clinical studies towards internal medicine equitable research

14. European Reference Network for Rare Vascular Diseases (VASCERN): When and how to use intravenous bevacizumab in Hereditary Haemorrhagic Telangiectasia (HHT)?

15. Efficacy and safety of lomitapide in familial chylomicronaemia syndrome

16. Worldwide experience of homozygous familial hypercholesterolaemia: retrospective cohort study

20. Impact of electronic cigarettes (e-cigs) and heat-not-burn/heated tobacco products (HnB/HTP) on asthma and chronic obstructive pulmonary disease: a viewpoint of the Italian Society of Internal Medicine.

21. Homozygous familial hypercholesterolemia in Italy: Clinical and molecular features

23. Characterization of epidemiological distribution and outcome of COVID-19 in patients with hereditary hemorrhagic telangiectasia: a nationwide retrospective multi-centre study during first wave in Italy

24. Long-term efficacy of lipoprotein apheresis and lomitapide in the treatment of homozygous familial hypercholesterolemia (HoFH): a cross-national retrospective survey

25. Hospital Care of Older Patients With COPD: Adherence to International Guidelines for Use of Inhaled Bronchodilators and Corticosteroids

27. Familial hypercholesterolaemia in children and adolescents from 48 countries: a cross-sectional study

28. Evaluation of the performance of Dutch Lipid Clinic Network score in an Italian FH population: The LIPIGEN study

29. Refinement of the diagnostic approach for the identification of children and adolescents affected by familial hypercholesterolemia: Evidence from the LIPIGEN study

30. Thyroid nodule malignancy is associated with increased non-invasive hepatic fibrosis scores in metabolic subjects

32. Spectrum of mutations in Italian patients with familial hypercholesterolemia: New results from the LIPIGEN study

33. Familial hypercholesterolemia: The Italian Atherosclerosis Society Network (LIPIGEN)

36. European Reference Network for Rare Vascular Diseases (VASCERN) position statement on cerebral screening in adults and children with hereditary haemorrhagic telangiectasia (HHT)

37. Clinical Approach in the Management of Paediatric Patients with Familial Hypercholesterolemia: A National Survey Conducted by the LIPIGEN Paediatric Group

38. Total serum FGF-21 levels positively relate to visceral adiposity differently from its functional intact form

39. Clinical Approach in the Management of Paediatric Patients with Familial Hypercholesterolemia: A National Survey Conducted by the LIPIGEN Paediatric Group

40. Lipoprotein(a) Genotype Influences the Clinical Diagnosis of Familial Hypercholesterolemia

42. Identification of a Novel Score for Adherence to the Mediterranean Diet That Is Inversely Associated with Visceral Adiposity and Cardiovascular Risk: The Chrono Med Diet Score (CMDS)

44. Efficacy of Lomitapide in the Treatment of Familial Homozygous Hypercholesterolemia: Results of a Real-World Clinical Experience in Italy

45. Prevalence and Determinants of the Use of Lipid-Lowering Agents in a Population of Older Hospitalized Patients: the Findings from the REPOSI (REgistro POliterapie Società Italiana di Medicina Interna) Study

47. Low HDL-cholesterol levels predict hepatocellular carcinoma development in individuals with liver fibrosis

49. European Reference Network for Rare Vascular Diseases (VASCERN): When and how to use intravenous bevacizumab in Hereditary Haemorrhagic Telangiectasia (HHT)?

Catalog

Books, media, physical & digital resources